Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 9
2012 4
2013 16
2014 9
2015 10
2016 7
2017 4
2018 4
2019 13
2020 7
2021 7
2022 7
2023 11
2024 7
2025 7
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.
Fisher BA, Mariette X, Papas A, Grader-Beck T, Bootsma H, Ng WF, van Daele PLA, Finzel S, Noaiseh G, Elgueta S, Hermann J, McCoy SS, Akpek E, Bookman A, Sopala M, Montecchi-Palmer M, Luo WL, Scheurer C, Hueber W; TWINSS study group. Fisher BA, et al. Among authors: finzel s. Lancet. 2024 Aug 10;404(10452):540-553. doi: 10.1016/S0140-6736(24)01211-X. Epub 2024 Jul 31. Lancet. 2024. PMID: 39096929 Clinical Trial.
Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial.
Venhoff N, Schmidt WA, Bergner R, Rech J, Unger L, Tony HP, Finzel S, Andreica I, Kofler DM, Weiner SM, Lamprecht P, Schulze-Koops H, App C, Pournara E, Mendelson MH, Sieder C, Maricos M, Thiel J. Venhoff N, et al. Among authors: finzel s. Lancet Rheumatol. 2023 Jun;5(6):e341-e350. doi: 10.1016/S2665-9913(23)00101-7. Lancet Rheumatol. 2023. PMID: 38251601 Clinical Trial.
Editorial: Reproducibility and rigour in rheumatology.
Silva A, Fonseca JE, Finzel S. Silva A, et al. Among authors: finzel s. Front Med (Lausanne). 2024 Mar 28;11:1402043. doi: 10.3389/fmed.2024.1402043. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38606158 Free PMC article. No abstract available.
Erratum zu: Vorschlag der rheumatologischen Fachgesellschaften im D-A-CH-Raum für eine einheitliche deutschsprachige Nomenklatur der Sjögren-Erkrankung.
Ernst D; die Deutsche Gesellschaft für Rheumatologie und klinische Immunologie e. V. (DGRh); Dörner T, Aringer M, Finzel S, Christ L; die Schweizerische Gesellschaft für Rheumatologie (SGR); Dan D, Dumusc A, Haase I, Kötter I, Meinecke A, Müller-Ladner U, Riemekasten G, Schmalzing M, Specker C, Duftner C; die Österreichische Gesellschaft für Rheumatologie und Rehabilitation (ÖGR); Stradner MH, Studenic P, Tausche AK, Thiel J, Wagner U, Witte T. Ernst D, et al. Among authors: finzel s. Z Rheumatol. 2026 Apr 27. doi: 10.1007/s00393-026-01816-2. Online ahead of print. Z Rheumatol. 2026. PMID: 42043507 German. No abstract available.
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment.
Agmon-Levin N, Ignatenko S, Gordienko A, Cortés-Hernández J, Narongroeknawin P, Romanowska-Próchnicka K, Shen N, Ciferská H, Kodera M, Cheng-Chung WJ, Leszczynski P, Lan JL, Mysler E, Wojciechowski R, Tarr T, Vishneva E, Chen YH, Kaneko Y, Finzel S, Hoi A, Okada M, Koolvisoot A, Lee SS, Lie D, Kaneko H, Rojkovich B, Sun L, Zotkin E, Viallard JF, López BPM, Ghanshani SA, Lau C, Avrameas A, Sips C, Oliver SJ. Agmon-Levin N, et al. Among authors: finzel s. Ann Rheum Dis. 2026 Mar;85(3):476-488. doi: 10.1016/j.ard.2025.11.015. Epub 2025 Dec 5. Ann Rheum Dis. 2026. PMID: 41353079 Free article. Clinical Trial.
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.
Spiera R, Kuwana M, Khanna D, Hummers L, Frech TM, Stevens W, Matucci-Cerinic M, Kafaja S, Distler O, Jun JB, Levy Y, Leszcyzński P, Gordon J, Steen V, Lee EB, Jankowski T, Litinsky I, Chung L, Hsu V, Mayes M, Sandorfi N, Simms RW, Finzel S, de Vries-Bouwstra J, Constantine S, Dgetluck N, Dinh Q, Bloom BJ, Furst DE, White B, Denton CP; RESOLVE-1 Study Group. Spiera R, et al. Among authors: finzel s. Arthritis Rheumatol. 2023 Sep;75(9):1608-1618. doi: 10.1002/art.42510. Epub 2023 Jun 15. Arthritis Rheumatol. 2023. PMID: 37098795 Free article. Clinical Trial.
[Immunopathogenesis of systemic lupus erythematosus].
Aringer M, Finzel S, Voll RE. Aringer M, et al. Among authors: finzel s. Z Rheumatol. 2024 Feb;83(1):68-76. doi: 10.1007/s00393-022-01214-4. Epub 2022 May 13. Z Rheumatol. 2024. PMID: 35551439 Free PMC article. Review. German.
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study.
Hess A, Tascilar K, Schenker HM, Konerth L, Schönau V, Sergeeva M, Kreitz S, Prade J, Strobelt S, Selvakumar M, Kleyer A, Englbrecht M, Hueber AJ, Zaiss MM, Feist E, Burmester GR, Voll RE, Finzel S, Baerwald C, Rösch J, Behrens F, Koehm M, da Silva JAP, Damjanov N, Dörfler A, Schett G, Rech J. Hess A, et al. Among authors: finzel s. Lancet Rheumatol. 2025 Aug;7(8):e565-e575. doi: 10.1016/S2665-9913(25)00032-3. Epub 2025 Jun 23. Lancet Rheumatol. 2025. PMID: 40570879 Free article. Clinical Trial.
[Diagnostics of Sjögren's disease].
Finzel S. Finzel S. Z Rheumatol. 2026 Apr 17. doi: 10.1007/s00393-026-01801-9. Online ahead of print. Z Rheumatol. 2026. PMID: 41995735 Review. German.
[Pathogenesis of systemic lupus erythematosus].
Finzel S, Schaffer S, Rizzi M, Voll RE. Finzel S, et al. Z Rheumatol. 2018 Nov;77(9):789-798. doi: 10.1007/s00393-018-0541-3. Z Rheumatol. 2018. PMID: 30291433 Review. German.
104 results